Thermo Fisher Scientific Inc. (NYSE:TMO)

A significant strategic shift in the revenue composition is evident over the analyzed period. Product revenues, which initially constituted 79.31% of total revenues in April 2021, experienced a consistent decline, stabilizing between 57% and 59% by 2024 and 2025. Conversely, service revenues grew from 20.69% to consistently exceeding 40% starting in 2023, indicating a structural transition toward a more service-oriented business model.

Gross Profitability and Cost Structure

Gross profit margins underwent a period of contraction, falling from a peak of 52.58% in April 2021 to a low of 38.66% in April 2023. This decline is primarily attributed to the rising cost of service revenues, which increased from -13.83% to approximately -30% of total revenues. While the cost of product revenues remained relatively stable—fluctuating between -28% and -36%—the overall gross margin eventually stabilized in the 40% to 42% range throughout 2024 and 2025.

Operating Expense Management

Selling, general and administrative (SG&A) expenses have remained remarkably consistent, generally oscillating between 19% and 21% of revenues. Research and development (R&D) spending has also shown high stability, consistently representing approximately 3% of total revenues. Restructuring and other costs have been sporadic, with a notable peak of -2.01% in December 2024, though they typically remain below 1% of revenues.

Operating and Net Income Trends

Operating income margins mirrored the trend of gross profit, decreasing from 30.78% in early 2021 to a trough of 14.59% in April 2023. Following this decline, margins recovered and stabilized between 16% and 18% from late 2023 through 2026. Net income attributable to the company followed a similar trajectory, starting at 23.59% and stabilizing in the 14% to 16% range in the latter half of the period.

Financial and Tax Obligations

Interest income saw a marked increase, rising from 0.12% in 2021 to a peak of 2.84% in December 2023, before settling around 1.7% to 2.1%. This was accompanied by an increase in interest expenses, which grew from -1.26% to a peak of -3.72% in June 2025, suggesting an increase in leverage or higher borrowing costs. Provision for income taxes fluctuated significantly, showing a general trend of reduction from 4.20% in early 2021 to lower levels, frequently remaining below 1.5% in more recent quarters.

Overall, the financial profile reflects a transition from a product-heavy revenue stream with high margins to a balanced product-service mix with a more stabilized, albeit lower, margin profile. The consistency in SG&A and R&D spending indicates disciplined operational overhead management despite the shift in business composition.